Dr Andrew Evans
Clinical (Associate Professor)
Department of Medicine
215 Scholarly works
12 Projects
HIGHLIGHTS
2026
Journal article
The effects of anti-Parkinsonian medications on bone mineral density: A systematic review
DOI: 10.1016/j.bone.2026.1178732026
Journal article
Fixed-Dose Tavapadon for Early Parkinson Disease: A Randomized Clinical Trial
DOI: 10.1001/jamaneurol.2026.05902026
Journal article
Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results
DOI: 10.1007/s40120-026-00948-62025
Journal article
The diagnostic pathway of Parkinson’s disease: understanding patient perspectives in Australia
DOI: 10.1038/s41531-025-00968-32025
Research grants (ARC, NHMRC, MRFF)
Implementing ParkinsonNet to Improve Equitable Access to High Quality Care for People With Parkinson's Disease in Rural and Remote Australia
2020
Research grants (ARC, NHMRC, MRFF)
Mind: Markers in Neuropsychiatric Disorders
2020
Research Grant
Mind: Markers in Neuropsychiatric Disorders
RECENT SCHOLARLY WORKS
2025
Journal article
Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear Palsy
DOI: 10.1002/mds.700262025
Journal article
Brain Networks Route Neurodegeneration Patterns in Patients with Progressive Supranuclear Palsy
DOI: 10.1002/mds.302572025
Journal article
Blood biomarker profiles in young-onset neurocognitive disorders: A cohort study
DOI: 10.1177/000486742413128052025
Journal article
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies
DOI: 10.1177/1877718X2413002952025
Journal article
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort
DOI: 10.1007/s00415-024-12732-32024
Journal article
Multi‐omic blood biomarkers and cognitive profiles discriminate causes of younger‐onset neurocognitive symptoms: a cohort study
DOI: 10.1002/alz.085786
RECENT PROJECTS
2020
Research Grant
Mind: Markers in Neuropsychiatric Disorders
2020
Research Grant
Mind: Markers in Neuropsychiatric Disorders